ABP – abpro holdings, inc (US:AMEX)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

ABP

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

1/15

07:00 am

abp

Abpro’s Lead Program ABP-102 Featured in Celltrion Presentation at the 44th Annual J.P. Morgan Healthcare Conference

Medium Report

Abpro’s Lead Program ABP-102 Featured in Celltrion Presentation at the 44th Annual J.P. Morgan Healthcare Conference

Report

1/6

08:27 am

abp

Abpro and Celltrion, Inc. Announce U.S. FDA IND Clearance for Lead Multispecific Antibody Cancer Candidate ABP-102 / CT-P72 [Yahoo! Finance]

High Report

Abpro and Celltrion, Inc. Announce U.S. FDA IND Clearance for Lead Multispecific Antibody Cancer Candidate ABP-102 / CT-P72 [Yahoo! Finance]

Report

1/6

07:00 am

abp

Abpro and Celltrion, Inc. Announce U.S. FDA IND Clearance for Lead Multispecific Antibody Cancer Candidate ABP-102 / CT-P72

High Report

Abpro and Celltrion, Inc. Announce U.S. FDA IND Clearance for Lead Multispecific Antibody Cancer Candidate ABP-102 / CT-P72

Report

12/30

04:09 pm

abp

Abpro (NASDAQ:ABP) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Low Report

Abpro (NASDAQ:ABP) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Report

12/23

04:09 pm

abp

Abpro (NASDAQ:ABP) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Medium Report

Abpro (NASDAQ:ABP) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.